← Back to catalogue

Vigilant Drug'Lib AGILIA US

FDA UDI

Class II (US FDA UDI)

by Fresenius Kabi

Identity

Trade Name
Vigilant Drug'Lib AGILIA US FDA UDI
Generic Name
Infusion pump medication-dosage application software FDA UDI
Device Name
Vigilant Drug'Lib AGILIA US is a dose error reduction software. It is installed on a PC Platform for communication with the Volumat MC Agilia infusion pump via a USB cable FDA UDI
Model / Reference
1.2 FDA UDI
Description
Vigilant Drug'Lib AGILIA US is a dose error reduction software. It is installed on a PC Platform for communication with the Volumat MC Agilia infusion pump via a USB cable FDA UDI

Identifiers

Catalog Number
Z073476 FDA UDI
Primary DI / UDI-DI
04052682034121 FDA UDI
510(k) Number
K121613 FDA UDI
FDA Product Code
FRN FDA UDI
GMDN Term
Infusion pump medication-dosage application software FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
880.5725 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Infusion pump medication-dosage application software

Vigilant Drug'Lib AGILIA US by Fresenius Kabi — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Infusion pump medication-dosage application software.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Fresenius Kabi

Sources (1)

  • FDA UDI a872fa76-2db1-408e-8a93-7c2b775e687c 35 fields · synced May 30, 2026